Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share from the same period last year.
Related Posts
What’s Going On With Mullen Automotive Stock?
Mullen Automotive, Inc. (NASDAQ: MULN) shares are trading higher Tuesday. The stock has lost more than 50% of its value over the last month.
What To Know:
Bitcoin Accepted: European Country Moves To Allow Payments For Government Services
Liechtenstein's government is considering the acceptance of Bitcoin (CRYPTO: BTC) as a form of payment for various state services, according to Prime Minister Daniel Risch.